|
|
Volumn 44, Issue 3, 2008, Pages 171-181
|
|
Ivabradine: If inhibition in the management of stable angina pectoris and other cardiovascular diseases
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTILIPEMIC AGENT;
ATENOLOL;
CALCIUM CHANNEL BLOCKING AGENT;
CORALAN;
CORAXAN;
CORLENTOR;
IVABRADINE;
KETOCONAZOLE;
NITRATE;
PLACEBO;
PROPRANOLOL;
ADD ON THERAPY;
BRADYCARDIA;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONGESTIVE HEART FAILURE;
DOSE RESPONSE;
DRUG ANALYSIS;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HEART FUNCTION;
HEART HEMODYNAMICS;
HEART MUSCLE ISCHEMIA;
HEART RATE;
HUMAN;
HYPERTENSION;
MONOTHERAPY;
NONHUMAN;
REVIEW;
STABLE ANGINA PECTORIS;
VISUAL DISORDER;
ANGINA PECTORIS;
ANIMALS;
BENZAZEPINES;
CARDIOTONIC AGENTS;
CARDIOVASCULAR DISEASES;
HEART RATE;
HUMANS;
|
|
EID: 43449097248
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2008.44.3.1193864 Document Type: Review |
|
Times cited : (25)
|
|
References (42)
|
